Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years - Kimball, A B; Gordon, K B; Fakharzadeh, S; Yeilding, N; Szapary, P O; Schenkel, B; Guzzo, C; Li, S; Papp, K A (Br J Dermatol, 2012)